Previous Article | Next Article 
Infect Immun, February 1998, p. 573-580, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Activation of Bovine Lymphocyte Subpopulations by
Staphylococcal Enterotoxin C
Witold A.
Ferens,1
William C.
Davis,2
Mary Jo
Hamilton,2
Yong H.
Park,3
Claudia F.
Deobald,1
Lawrence
Fox,4 and
Gregory
Bohach1,*
Department of Microbiology, Molecular Biology
and Biochemistry, University of Idaho, Moscow, Idaho
838441;
Department of Veterinary
Microbiology and Pathology2 and
Department of Veterinary Clinical Medicine and
Surgery,4 Washington State University, Pullman,
Washington 99164; and
Department of Microbiology, College
of Veterinary Medicine, Seoul National University, Suwon 441-744, Korea3
Received 22 July 1997/Returned for modification 16 October
1997/Accepted 17 November 1997
 |
ABSTRACT |
Staphylococcus aureus is a major mastitis-causing
pathogen in cattle. The chronic nature of bovine staphylococcal
mastitis suggests that some products or components of S. aureus may interfere with the development of protective
immunity. One class of molecules that could be involved are
superantigens (SAgs). Although a significant number of
mastitis isolates produce SAgs, the effect of these molecules on the
bovine immune system is unresolved. To determine if
immunosuppression caused by SAgs could play a role in pathogenesis, we
monitored bovine lymphocytes exposed to staphylococcal enterotoxin C1
(SEC1). Activation of bovine lymphocytes by either SEC1 or concanavalin A (ConA) was influenced by the 
/
T-cell ratio in the culture. Compared to ConA-induced stimulation, cultures stimulated with SEC1 generated small numbers of CD4+ 
T cells expressing high levels of interleukin-2 receptor
chain (IL-2R
) and major histocompatibility complex class II (MHCII), suggesting that SAg exposure does not lead to full activation of these
cells. This state of partial activation was most pronounced in cultures
with a high 
/
ratio. In contrast, significant numbers of
CD8+ 
T cells expressed high levels of IL-2R
and
MHCII, regardless of the 
/
ratio and the stimulant used.
CD8+ blasts in cultures stimulated with SEC1 also expressed
another activation marker, ACT3, previously detected predominantly on thymocytes and CD4+ T cells. Although 
CD2
and CD2+ T cells expressed MHCII and
IL-2R
following stimulation with SEC1, only a few cells increased to
blast size, suggesting that they were only partially activated. The
results suggest ways in which SAgs might facilitate immunosuppression
that promotes the persistence of bacteria in cattle and contributes to
chronic intramammary infection.
 |
INTRODUCTION |
Staphylococcus aureus is
a prominent pathogen in bovine mastitis (24). This organism
is frequently isolated from milk (2, 16, 40) and from cows
with intramammary infection (IMI) (17). IMI caused by
S. aureus tends to become chronic and may resist antibiotic
therapy (49). It has been postulated that persistent infection with S. aureus is associated with an impairment of
the immune response, mediated by factors produced by S. aureus (34). Thus far, however, no single factor has
been clearly implicated.
Bovine isolates of S. aureus frequently produce one or more
pyrogenic toxins (PTs), especially types C and D staphylococcal enterotoxins (SEs) and toxic shock syndrome toxin (24). The staphylococcal PTs are prototype microbial superantigens (SAgs), characterized by the ability to bind to major histocompatibility complex class II (MHCII) molecules and to specific V
segments of

T-cell receptor (TCR) outside the binding groove associated with
MHC-restricted immune system recognition of processed peptides. By
bypassing antigenic specificity, SAgs stimulate abnormally large
numbers of T cells and are able, at nanomolar concentrations, to induce
T-cell proliferation (33). Few studies have been performed to investigate the effects of SAgs on the bovine immune system (53); most studies have involved other animals. In several
species, SAgs exert wide-ranging and deleterious effects, including
induction of shock (4), T-cell unresponsiveness and deletion
(23), differential stimulation of CD4+ and
CD8+ T-cell subsets (47), and B-cell
differentiation (46). Thus, although largely unconfirmed,
there is a clear potential for SEs, and other SAgs, to modulate immune
responses and contribute to the virulence and persistence of S. aureus in cattle.
The T-cell population consists of cells expressing either the 
TCR (TCR2) or the 
TCR (TCR1). While the roles of 
T cells
in immune responses of many species have been well characterized, the
function of 
T cells is less well understood (22).
This is especially true in ruminants. Recent investigations have shown that the ruminant 
T cells comprise two disparate subpopulations, characterized by constitutive expression of cell surface molecules. One
subpopulation, similar in composition and tissue distribution to 
T cells from other species, consists of cells that express CD2, CD5,
and CD6 and are positive or negative for CD8 (10). These
cells are present in low concentrations (3 to 5%) in peripheral blood
and in high concentrations (35 to 40%) in spleen, gut epithelium, and
mammary gland secretions (41). The second subpopulation, negative for CD2, CD6, and CD8, is unique and has been identified in
only one other member of the Artiodactyla, swine (3, 28). This subpopulation is positive for CD5 and two lineage-restricted molecules, workshop cluster 1 (WC1) (32, 36, 50) and GD3.5 (21). The concentration of WC1+
GD3.5+ CD2
CD6

T cells
is high (30 to 50%) in the peripheral blood in young ruminants,
decreasing with age, and is low (3 to 8%) in secondary lymphoid
tissues and mammary gland secretions (41, 52). Definitive data on the function of either of these major subpopulations of 
T cells have not been obtained. However, previous studies have suggested that they may be involved in regulating the proliferative response of CD4+ T cells to antigens (7).
Park et al. (42) identified a subset of T cells, positive
for CD2 and CD8, in mammary gland secretions of cows infected with
S. aureus. These cells had the ability to inhibit the
proliferative response of bovine CD4+ cells to
staphylococcal antigens (42). Although the mechanisms by
which these cells were induced and mediated their effect were not
determined, they clearly have the potential to contribute to the
pathogenesis of staphylococcal IMI. Although not all bovine staphylococcal isolates produce known SAgs, it is important to determine whether SAg production could induce these or other
immunosuppressive subpopulations in cows and promote the development of
some infections such as IMI. The objective of this study was to extend
these initial observations. We examined the effect of a representative
SAg (SEC1) on the major subpopulations of bovine 
and 
T
cells.
 |
MATERIALS AND METHODS |
SEC1 purification.
SEC1 was purified from S. aureus (pMIN121), a recombinant harboring the
secMNDON structural gene cloned into a
nontoxigenic background (strain RN4220) (4, 19). Cultures
were grown with aeration at 37°C in pyrogen-free dialyzable beef
heart medium containing erythromycin (50 µg/ml). SEC1 was purified to
homogeneity by standard preparative flat-bed isoelectric focusing
techniques (44) with broad- and narrow-pH-range ampholytes
in succession. Fractions containing purified toxin were identified by
immunodiffusion, and the degree of purity was assessed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (26).
Ampholytes were removed from the toxin solution by exhaustive dialysis
against pyrogen-free water.
Animals.
Purebred adult healthy Holstein-Frisian cattle were
screened as prospective donors and for determination of the relative
amounts of 
and 
T cells in their systemic circulation.
Most experiments were performed with cells from two selected donors:
one with a low concentration of 
T cells (13%) and the other
with high concentration (82%) (designated donors A and F,
respectively). Donor A (low 
) was a 5-year-old dairy cow from the
University of Idaho dairy farm, Moscow, Idaho. Donor F (high 
)
was a 2.5-year-old steer, housed at Washington State University,
Pullman, Wash. The animals were maintained according to Association for
the Assessment and Accreditation of Laboratory Animal Care,
International, guidelines and regulations established by the Animal
Care and Use Committees at Washington State University and the
University of Idaho.
Blood collection and cell culture.
Collection, processing,
and conditions for culturing of peripheral blood mononuclear cells
(PBMC) were described previously (42). PBMC suspensions were
adjusted to 2.0 × 106 cells per ml and incubated in
plastic petri dishes for 4, 24, or 96 h at 37°C in 5%
CO2. The final concentrations of stimulants in cultures
(SEC1, 0.1 µg/ml; concanavalin A ConA, 5.0 µg/ml) constituted the
doses found to induce optimal T-cell proliferation in dose response
assays (results not shown). Concanavalin A (ConA) was purchased from
Sigma Chemical Co., St. Louis, Mo.
Flow cytometry.
Before and after stimulation in culture, the
cells were processed for single or multiple color flow cytometric
analysis by established techniques (11). The monoclonal
antibodies used in this study to detect cell surface molecules are
listed in Table 1. Polyclonal and
isotype-specific anti-mouse immunoglobulins (prepared in goats)
conjugated to fluorescein isothiocyanate, phycoerythrin, or Tri-color
(Caltag Laboratories, Burlingame, Calif.) were used as
second-step reagents. Flow cytometric data were acquired
with a FACSort apparatus equipped with a Macintosh computer and
CellQuest software (Becton-Dickinson Immunocytometry Systems, San Jose,
Calif.). The forward and side scatter gates for bovine leukocytes were
set to exclude cell debris and dead cells. Typically, 5,000 events were
acquired per sample. When necessary, gates were set on small
subpopulations to collect 2,000 events for analysis. Analyses were
performed with the CellQuest, PAINT A GATE, or ATTRACTORS analytical
program. Specific subpopulations of cells were quantified by using
fixed attractors, with a cutoff line at 1.1 log unit. Expression of
interleukin-2 receptor
chain (IL-2R
) was separated into high-
and low-intensity categories, i.e., above and below 2.0 log units.
Large cells, considered to be blasts, were readily identifiable on
plots of linear forward/log right-angle light scatter. A cutoff value
of linear forward light scatter, usually >612 channels, was set to
distinguish small cells (comprising cells at a low or partial level of
activation) from large (blast) cells. The data for these experiments
are presented as an index of blastogenesis, which refers to the
percentage of large cells in a given subpopulation.
Statistical analysis.
Data on the expression of activation
molecules are presented as arithmetic mean ± standard error of
the mean (SEM) of triplicate measurements. To ascertain statistical
significance of changes in cell numbers, a two-tailed t test
(54) was performed on the counts after square root
transformation, with P < 0.01 indicating significance.
 |
RESULTS |
Stimulation of bovine PBMC by SEC1 is unique and appears to be
influenced by 
T cells.
The percentage of 
T cells
expressing WC1 and GD3.5 (referred to here as CD2

T cells) varies in bovine blood from over 80% in young animals to
<10% in adults (52). Since this subpopulation of 
T
cells has been reported to modulate 
T-cell responses (5, 7, 8, 52), the composition and general proliferative responses of
PBMC from several prospective donors were assessed. As shown in Fig.
1, cumulative data from six animals
revealed a marked difference in the proliferative response of
CD4+ T cells to SEC1 in the presence of different
concentrations of 
T cells, consistent with previous observations
that indicated that 
T cells regulate activation of
CD4+ T cells. Two initial observations pointed to a
potential inhibitory effect mediated by 
T cells on SEC1-induced
stimulation of CD4+ T cells. First, the relative percent of
CD4+ T cells in cultures from all six donors declined
during 96 h in the presence of SEC1. This decline was most
prominent in cultures containing a high concentration of 
T
cells. Second, most of the CD4+ T cells in cultures with a
high concentration of 
T cells did not increase to blast size. A
reduction in the percentage of 
T cells expressing CD8 was also
observed with some donors. However, this reduction was smaller than
that noted for CD4+ T cells and was evident only in
cultures with high concentrations of 
T cells (donors D, E, and
F). In contrast to CD4+, most CD8+ T cells were
blast size after 96 h of culture, even in cultures derived from
animals with high concentrations of 
T cells in peripheral blood.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Influence of  T cells on CD4+ and
CD8+ T cells in PBMC cultures following a 96-h incubation
with SEC1. Data are percentages of T cells obtained in a representative
experiment. Donors A through F were healthy Holstein-Frisian cattle
differing in  / T-cell ratios as indicated in the figure.
Each of the six donors was tested in the following number of replicate
experiments: donor A, 7; donor B, 2; donor C, 3; donor D, 4; donor E,
3; and donor F, 6. They consistently yielded similar results.
|
|
Since these results suggested that 
T cells modulate the response
of 
T cells to SAgs and to mitogens, donors representing animals
from opposite ends of the spectrum of the 
/
T-cell ratio
(donors A and F) were compared in subsequent analyses. T-cell subpopulations in cultures from these two donors were quantified in a
proliferation assay and by flow cytometry. In a standard 4-day
lymphocyte proliferation assay, based on incorporation of tritiated
thymidine following stimulation with SEC1, PBMC from donor F (high

) were at least 1,000-fold less responsive to SEC1 than were PBMC
from donor A (low 
) (Fig. 2A).
Subpopulation analysis by flow cytometry showed that SEC1 induced a
statistically significant expansion in the numbers of 
CD8+ cells and CD2

T cells in cultures
of PBMC from donor A (Fig. 2B). However, there was no statistically
significant net increase in other subpopulations, including
CD4+ cells, after 96 h. The CD4+ cells
from donor A were potentially responsive since they proliferated in
identical cultures stimulated with ConA. In fact, most major T-cell
subpopulations expanded when ConA was used to stimulate cultures
derived from donor A. The one exception was the 
CD2+
subpopulation, which did not expand over the 96-h culture period (Fig.
2B).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Proliferative responses of bovine PBMC in cultures
stimulated with SEC1. Data are means of triplicate measurements ± SEM. (A) Incorporation of [3H]thymidine in a standard
4-day proliferation assay. (B) Changes in cell numbers within bovine
T-cell subpopulations following a 96-h culture of PBMC with SEC1 or
ConA. Statistically significant increases (P < 0.01)
are indicated (*).
|
|
In contrast, cells from donor F failed to respond to SEC1 or showed a
consistently low response following stimulation with SEC1. As with
donor A, stimulation of parallel cultures with ConA demonstrated that
the donor F cells were capable of proliferating and that multiple
subpopulations expanded.
Lack of correlation between SEC1-induced blastogenesis and
proliferation.
As shown in Fig. 2B, the net increase in cell
number in cultures derived from donor A cells and stimulated with SEC1
was attributed to the expansion of CD8+ cells.
Interestingly, though, subsequent experiments suggested that SEC1
partially activates other subpopulations of T cells, presumably through
signaling pathways that do not lead to cell division. Analysis of
forward and side light scatter patterns of cells from cultures
stimulated with SEC1 revealed that many cells had increased in cell
size, consistent with the early events of cell activation and
blastogenesis. Stimulation with SEC1 caused a significant increase in
the number of blast-sized cells within several T-cell subpopulations,
especially in cultures with a low concentration of 
T cells. The
majority (76.9%) of CD8+ and a lower but significant
(53.9%) percentage of CD4+ cells reached blast size in
cultures derived from donor A (Table 2),
even though there was no net increase in the number of CD4+
cells at 96 h.
SEC1-induced blastogenesis within both CD4+ and
CD8+ T-cell subpopulations was low in cultures from donor F
(21.3 and 41.3%, respectively) compared to cultures from donor A
(Table 2). There was no apparent influence, by 
T cells from
either donor, over the level of blastogenesis induced by ConA.
Activation of CD4+ cells by SEC1.
T-cell
activation is typically associated with sequential upregulation of
several IL receptors and other cell-surface molecules. For example,
following activation, IL-2R expression may be upregulated within hours,
followed by upregulation of MHCII molecules on T cells. To further
analyze factors affecting CD4+ T-cell activation, we
measured the expression of IL-2R
and MHCII to monitor the
progression of T cells through early and late stages of activation.
Since the expression of IL-2R
is affected by both constitutive and
inducible factors, the density of this receptor on the surface varies
depending on the level of stimulation (1). High-density
expression requires IL-2R
gene transcription as well as mRNA
stabilization (6). Flow cytometric dot plots, of
SEC1-stimulated cells labeled with anti-IL-2R
and one additional antibody (for phenotyping the cell population under study), were used
to distinguish between low- and high-density expression. Cells with
low-density expression were defined as cells with fluorescence staining
intensities less than 2.0 log units; cells considered to have high
density expression had intensities above 2.0 log units.
Similar to reports for human and murine peripheral blood
(39), a substantial number of CD4+ (30 to 40%)
bovine lymphocytes expressed low but significant levels of IL-2R
(IL-2R
low) prior to stimulation (Fig.
3A). The numbers of
IL-2R
low CD4+ cells did not change
substantially in cultures stimulated with SEC1, although they increased
severalfold in ConA-stimulated cultures. CD4+ cells
expressing high levels of IL-2R
(IL-2R
high), typical
of cells in an early and highly activated state, were rarely detected
prior to stimulation. Examination of this subpopulation revealed major
differences in the fate of CD4+ cells from both donors A
and F and between SEC1-induced and ConA-induced stimulation. A
comparison of results from the two donors confirmed observations from
the initial experiments which indicated that 
T cells strongly
affect the activation of CD4+ cells by SEC1. For example,
an increase in the numbers of IL-2R
high CD4+
cells was evident in SEC1-stimulated cultures from donor A at 24 h
and was followed by further increase by 96 h. In contrast, only
small numbers of IL-2R
high CD4+ cells were
found at 24 h in SEC1-stimulated PBMC from donor F. Moreover, the
number of cells with high expression did not increase by 96 h, suggesting a loss of cells or downregulation of IL-2R
expression.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of IL-2R , MHCII, and ACT3 by
subpopulations of bovine T cells in PBMC cultures stimulated with SEC1
or ConA. Data are numbers of cells expressing a given marker (mean ± SEM of three measurements obtained in a representative experiment).
The cells expressing IL-2R are separated into nonoverlapping
populations characterized by a small or large amount of the receptor on
the cell surface. (A) CD4+ cells; (B) CD8+
cells. Data represented by the open and solid circles are means ± SEM of the total number of cells expressing CD4 or CD8 at each time
point.
|
|
The patterns of MHCII expression on CD4+ cells
following stimulation with either SEC1 or ConA were similar to the
patterns observed for expression of high levels of IL-2R
(Fig. 3A).
One difference between these markers was that, as expected, the
increase in MHCII expression was delayed compared to that of
IL-2R
. A small but significant increase in MHCII expression was
observed at 24 h in cultures of PBMC from donor A. The proportion
of MHCII+ CD4+ cells increased throughout
the 96-h culture period, with the exception of a minor decline during
the first 4 h. In contrast, although 20% of CD4+
cells in cultures of SEC1-stimulated PBMC from donor F expressed MHCII at 24 h, the number and proportion of MHCII-positive
CD4+ cells declined below baseline levels following 96 h of culture.
SEC1 induces an unique phenotype of activated CD8+
cells.
Activation molecule 3 (ACT3) is a 120-kDa membrane molecule
with no identified human or mouse ortholog (13, 42, 45). In
ConA-stimulated cultures of PBMC, ACT3 was expressed on at least 50%
of CD4+ cells after 96 h (Fig. 3A). Levels of ACT3
expression on CD4+ cells in donor A PBMC cultures,
stimulated with either SEC1 or ConA, were similar to the levels of
expression of IL-2R
high and MHCII (Fig. 3A). An
increase in the expression of ACT3 was clearly evident only in
ConA-stimulated cultures of PBMC from donor F. In contrast to
CD4+ cells, a much smaller proportion of CD8+
cells expressed ACT3 in ConA-stimulated cultures, but SEC1 induced ACT3
expression on more than 50% of CD8+ cells in culture from
donor A and on more than 40% of CD8+ cells in culture from
donor F (Fig. 3B). Most of the CD8+ blasts (60 to 80%)
were positive for ACT3 in SEC1-stimulated cultures, whereas fewer than
15% were positive in ConA-stimulated cultures (data not shown).
Combined, these data suggest that SEC1-induced expression of ACT3 on
bovine CD8+ T cells coincides with a highly activated
state.
Effect of SEC1 on 
T cells.
The responses of the
CD2
and CD2+ CD8+ subpopulations
of 
T cells differed. 
CD2+ CD8+
cells failed to expand in cultures stimulated with either ConA or SEC1
(Fig. 2B). The absence of proliferation correlated with minimal
activation, evidenced by low blastogenesis and moderate expression of IL-2R
(Table 2; Fig.
4A). In contrast to other T-cell
subpopulations, expression of MHCII was higher than expression of
IL-2R
at 96 h.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of IL-2R and MHCII on subpopulations
of bovine  T cells in PBMC cultures stimulated with SEC1 or ConA.
Data are numbers of cells positive for a given marker (mean ± SEM
of three measurements obtained in a representative experiment). The
cells positive for IL-2R are separated into nonoverlapping
populations characterized by small or large amounts of the receptor on
the cell surface. (A)  CD2+ CD8+ cells;
(B)  CD2 cells. Notice the different scale in
panels A and B.
|
|

CD2
cells in PBMC cultures from either donor were
potentially responsive to stimulation. Activation of these cells in
cultures stimulated by ConA resulted in proliferation (Fig. 2B),
expression of IL-2R
and MHCII (Fig. 4B), and enlargement to
blast size (Table 2). Activation was more pronounced in cultures of
cells from donor F (Fig. 4B). In contrast to ConA, SEC1 induced only
minimal blastogenesis within the 
CD2
population
(Table 2). This result correlated with a correspondingly low level of
IL-2R
and MHCII expression in this population of cells (Fig.
4B). The patterns obtained with CD2

T cells from
donor A were similar except for lower background levels, reflecting the
composition of T-cell population in this donor.
 |
DISCUSSION |
SAg-induced oligoclonal activation of T cells results from the
binding of SAgs to MHCII molecules and TCRs that bear specific V
gene products. For PT SAgs such as SEs and toxic shock syndrome toxin
type 1, structural data suggest this interaction does not bring the
peptide binding groove of the MHCII molecule in juxtaposition with
the TCR peptide binding pocket (15, 20, 25). Thus, cross-linking is sufficient to transduce signals of activation. How
these signals differ from those that occur following MHC-restricted immune system recognition has not been fully elucidated. However, it is
clear that SAg-mediated signaling is unique and that altered signaling
leads to a cascade of events associated with toxic shock syndrome and
aberrations in the function of lymphocytes (43).
The present study suggests that SAgs have the potential to affect the
bovine immune system in a manner that could promote staphylococcal
persistence and infections such as IMI. Comparing the response of PBMC
to ConA and SEC1 revealed differences in cell activation,
proliferation, and expression of activation molecules. Stimulation with
SEC1 led to partial activation of CD4+ T cells and 
T
cells as evidenced by the expression of MHCII and IL-2R
. A
significant number of CD4+ T cells also expressed ACT3 and
increased in size. However, proliferation was limited or absent. Few
CD2

T cells increased in size in 4-day cultures,
and there was no increase in the numbers of CD2+
CD8+ 
T cells in spite of some increase in cell size.
In contrast, stimulation with SEC1 led to activation and proliferation
of CD8+ T cells and the unique expression of the activation
molecule, ACT3. Of interest, the level of activation of
CD4+ and CD8+ T cells was affected by the
proportion of 
T cells present in the culture, suggesting that
these cells may play a modulatory role in the activation of 
T
cells. The evolution of the immune system in swine and ruminants is
unique since the 
T cell concentration is highly variable in
these animals (3, 5, 10, 21, 22, 32, 36, 41, 50, 51, 52).
Although 
T-cell levels are influenced by age, other factors,
such as prior disease or exposure, have not been shown to influence the

/
T cell ratio. Whether animals with high levels of 
T cells are more susceptible to infection, especially by SAg-producing
organisms, is one possibility currently under investigation.
Efforts to elucidate the mechanisms of SAg-driven T-cell responses in
other animals have shown that aberrant signaling induced by SAgs leads
to the production of multiple regulatory cytokines in vivo
(29). This is followed by deletion of cells expressing specific V
segments (30, 31) and anergy or
hyporesponsiveness to stimuli in the remaining cells (23,
35). Such hyporesponsiveness may be associated with
downregulation of the expression of IL-2R
and inhibition of JAK-3
kinase, demonstrated for human CD4+ T cells
(38). The present study of bovine cells is in agreement with
studies performed in other systems, showing that CD4+
T-cell function may be inhibited more than that of CD8+ T
cells by prolonged exposure to SAgs (9, 23). Long-term studies in vivo showed that CD8+ T cells predominate among
SAg-reactive T cells (i.e., those bearing specific V
segments)
surviving treatment with SAg (18, 31). The results obtained
in the present study are also in line with results of experiments with
mice, whereby treatment with SAgs gave rise to CD8+ T cells
with an altered phenotype and functional activity. Specifically, CD8+ cells isolated from mice treated with SAg were shown
to lack cytotoxic activity, although they were responsive to cytokines and retained the ability to proliferate (48). Further
studies are required to determine whether such cells could
modulate the activation and function of CD4+ T cells
through the production of cytokines that downregulate their capacity to
respond to stimuli.
Previous studies with T cells from cows have shown that a subpopulation
of activated CD8+ T cells downregulates the response of
CD4+ cells to staphylococcal antigens presented by
antigen-presenting cells (42). Elevated levels of these
CD8+ T cells were demonstrated in mammary secretions from
glands infected with S. aureus, indicating that they might
play a role in pathogenesis (42). Although the potential
role of microbial products in inducing these cells was not established,
the present study indicates that SAg-activated CD8+ T
cells may play a significant role in the pathogenesis of mastitis caused by SAg-producing S. aureus.
The activation of bovine CD8+ T cells by SEC1 occurs
through a mechanism that is associated with unique expression of ACT3, a 120-kDa molecule with no identified ortholog in any other species. Antibodies that recognize this molecule were assigned to workshop cluster 10 in the Second International Workshop on Ruminant Leukocyte Differentiation Antigens (45). High-level expression of ACT3 on activated CD8+ T cells has not been previously observed
and could be associated with the expression of cytokines that modulate
the capacity of CD4+ T cells to respond to mitogenic
stimuli. Previous studies have shown ACT3 is expressed predominantly by
CD4+ T cells in ConA-stimulated cultures (13).
More recently, investigations have shown that ACT3 is highly expressed
on CD4+ and 
T cells in long-term cultures derived
from animals stimulated with Babesia bovis (5).
Further studies are now needed to determine specifically whether
SEC1-activated CD8+ 
T cells affect the proliferative
and functional activity of CD4+ T cells.
This study also suggests that activation of CD4+ and
CD8+ T cells by SEC1 and, to a lesser degree, by ConA is
significantly influenced by the proportion of 
T cells present in
cultures. Since the content of 
T cells is a highly
variable characteristic of ruminants, the general susceptibility
of animals to SAg-mediated immunosuppression may vary greatly. The
mechanism of a putative regulatory influence of 
T cells remains
to be determined. It is not clear whether 
T cells in ruminants
can be activated directly through the binding of SAgs to the

TCR. However, expression of activation markers on their surface,
following exposure to SEC1, indicates that either direct or indirect
activation of 
T cells does occur.
In conclusion, evidence has been obtained which shows that SAgs could
induce immunosuppression in dairy animals and contribute to the
pathogenesis of staphylococcal mastitis. The staphylococcal SAg SEC1
induces a unique and aberrant activation of T-cell subpopulations. Further studies are warranted on this basis alone. However, the findings also suggest that the bovine system might serve as a useful
model for the investigation of the mechanisms by which SAgs modulate
immune system function and cause disease in other animals.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the U.S. Department of
Agriculture (project 9402399) and the Public Health Service (grant
AI28401).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, ID 83844. Phone: (208) 885-6666. Fax: (208) 885-6518. E-mail:
gbohach{at}uidaho.edu.
Editor: V. A. Fischetti
 |
REFERENCES |
| 1.
|
Algarte, M.,
P. Lecine,
R. Costello,
A. Plet,
D. Olive, and J. Imbert.
1995.
In vivo regulation of interleukin-2 receptor gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells.
EMBO J.
14:5060-5072[Medline].
|
| 2.
|
Bartlett, P. C.,
G. Y. Miller,
S. E. Lance, and L. E. Heider.
1992.
Clinical mastitis and intramammary infections on Ohio dairy farms.
Prev. Vet. Med.
12:59-71.
|
| 3.
|
Binns, R. M.
1994.
The null/ TCR+ T cell family in the pig.
Vet. Immunol. Immunopathol.
43:69-77[Medline].
|
| 4.
|
Bohach, G. A., and P. Schlievert.
1987.
Expression of staphylococcal enterotoxin C1 in Escherichia coli.
Infect. Immun.
55:428-432[Abstract/Free Full Text].
|
| 5.
|
Brown, W. C.,
W. C. Davis,
S. H. Choi,
D. A. E. Dobbelaere, and G. A. Splitter.
1994.
Functional and phenotypic characterization of WC1+ / T cells isolated from Babesia bovis-stimulated T cell lines.
Cell. Immunol.
153:9-27[Medline].
|
| 6.
|
Cerdan, C.,
Y. Martin,
M. Courcoul,
H. Brailly,
C. Mawas,
F. Birg, and D. Olive.
1992.
Prolonged IL-2 receptor /CD25 expression after T cell activation via the adhesion molecules CD2 and CD28.
J. Immunol.
149:2255-2261[Abstract].
|
| 7.
|
Chiodini, R. J., and W. C. Davis.
1992.
The cellular immunology of bovine paratuberculosis: the predominant response is mediated by cytotoxic gamma/delta T lymphocytes which prevent CD4+ activity.
Microb. Pathog.
13:447-463[Medline].
|
| 8.
|
Chiodini, R. J., and W. C. Davis.
1993.
The cellular immunology of bovine paratuberculosis: immunity may be regulated by CD4+ helper and CD8+ immunoregulatory T lymphocytes which down-regulate gamma/delta+ T cell cytotoxicity.
Microb. Pathog.
14:355-367[Medline].
|
| 9.
|
Damle, N. K.,
G. Leytze,
K. Klussman, and J. A. Ledbetter.
1993.
Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Eur. J. Immunol.
23:1513-1522[Medline].
|
| 10.
|
Davis, W. C.,
W. C. Brown,
M. J. Hamilton,
C. R. Wyatt,
J. A. Orden,
A. M. Khalid, and J. Naessens.
1996.
Analysis of monoclonal antibodies specific for the  TcR.
Vet. Immunol. Immunopathol.
52:275-283[Medline].
|
| 11.
|
Davis, W. C.,
J. E. Davis, and M. J. Hamilton.
1995.
Use of monoclonal antibodies and flow cytometry to cluster and analyze leucocyte differentiation molecules, p. 149-167. In
W. C. Davis (ed.), Monoclonal antibody protocols.
The Humana Press, Inc., Totowa, N.J.
|
| 12.
|
Davis, W. C.,
N. D. MacHugh,
Y. H. Park,
M. J. Hamilton, and C. R. Wyatt.
1993.
Identification of a monoclonal antibody reactive with the bovine orthologue of CD3 (BoCD3).
Vet. Immunol. Immunopathol.
39:85-91[Medline].
|
| 13.
|
Davis, W. C.,
J. Naessens,
W. C. Brown,
J. A. Ellis,
M. J. Hamilton,
G. H. Cantor,
J. I. R. Barbosa,
W. A. Ferens, and G. A. Bohach.
1996.
Analysis of monoclonal antibodies reactive with molecules upregulated or expressed only on activated lymphocytes.
Vet. Immunol. Immunopathol.
52:301-311[Medline].
|
| 14.
|
Davis, W. C., and G. S. Splitter.
1991.
Bovine CD2.
Vet. Immunol. Immunopathol.
27:43-50[Medline].
|
| 15.
|
Deringer, J. R.,
R. J. Ely,
C. V. Stauffacher, and G. A. Bohach.
1997.
Subtype-specific interactions of type C staphylococcal enterotoxins with the T-cell receptor.
Mol. Microbiol.
22:523-534.
|
| 16.
|
Fox, L. K.,
D. D. Gershman, and C. T. Hutton.
1991.
Fomites and reservoirs of Staphylococcus aureus causing intramammary infections as determined by phage typing: the effect of milking time hygiene practices.
Cornell Vet.
81:183-193[Medline].
|
| 17.
|
Gonzales, R. N.,
D. E. Jasper,
T. B. Farver,
R. B. Bushnell, and C. E. Franti.
1988.
Prevalence of udder infections and mastitis in 50 California dairy herds.
J. Am. Vet. Med. Assoc.
193:323-328[Medline].
|
| 18.
|
Herrmann, T.,
S. Baschieri,
R. K. Lees, and R. H. MacDonald.
1992.
In vivo responses of CD4+ and CD8+ cells to bacterial superantigens.
Eur. J. Immunol.
22:1935-1938[Medline].
|
| 19.
|
Hovde, C. J.,
J. C. Marr,
M. L. Hoffman,
S. P. Hackett,
Y.-I. Chi,
K. K. Crum,
D. L. Stevens,
C. V. Stauffacher, and G. A. Bohach.
1994.
Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1.
Mol. Microbiol.
13:897-909[Medline].
|
| 20.
|
Jardetzky, T. S.,
J. H. Brown,
J. C. Gorga,
L. J. Stern,
R. G. Urban,
Y. Chi,
C. Stauffacher,
J. L. Strominger, and D. C. Wiley.
1994.
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Nature
368:711-718[Medline].
|
| 21.
|
Jones, W. M.,
B. Walcheck, and M. A. Jutila.
1996.
Generation of a new  T cell-specific monoclonal antibody (GD3.5): biochemical comparisons of GD3.5 antigen with the previously described workshop cluster 1 (WC1) family.
J. Immunol.
156:3772-3779[Abstract].
|
| 22.
|
Kaufmann, S. H.
1996.
Gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?
Proc. Natl. Acad. Sci. USA
93:2272-2279[Abstract/Free Full Text].
|
| 23.
|
Kawabe, Y., and A. Ochi.
1990.
Selective anergy of V 8+, CD4+ T cells in Staphylococcus enterotoxin B-primed mice.
J. Exp. Med.
172:1065-1070[Abstract/Free Full Text].
|
| 24.
|
Kenny, K.,
R. F. Reiser,
F. D. Bastida-Corcuera, and N. L. Norcross.
1993.
Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus.
J. Clin. Microbiol.
31:706-707[Abstract/Free Full Text].
|
| 25.
|
Kim, J.,
R. G. Urban,
J. L. Strominger, and D. C. Wiley.
1994.
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.
Science
266:1870-1874[Abstract/Free Full Text].
|
| 26.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 27.
|
Larsen, R. A.,
M. L. Monaghan,
Y. H. Park,
M. J. Hamilton,
J. A. Ellis, and W. C. Davis.
1990.
Identification and characterization of monoclonal antibodies reactive with bovine, caprine and ovine T-lymphocyte determinants by flow microfluorimetry.
Vet. Immunol. Immunopathol.
25:195-208[Medline].
|
| 28.
|
Licence, S. T.,
W. C. Davis,
M. M. Carr, and R. M. Binns.
1995.
The behaviour of monoclonal antibodies in the First International Pig CD Workshop reacting with  /null T lymphocytes in the blood of SLAb/b line pigs.
Vet. Immunol. Immunopathol.
47:253-271[Medline].
|
| 29.
|
Litton, M. J.,
B. Sander,
E. Murphy,
A. O'Garra, and J. S. Abrams.
1994.
Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B.
J. Immunol. Methods
175:47-58[Medline].
|
| 30.
|
MacCormack, J. E.,
J. E. Callahan,
J. Kappler, and P. C. Marrack.
1993.
Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen.
J. Immunol.
150:3785-3792[Abstract].
|
| 31.
|
MacDonald, H. R.,
S. Baschieri, and R. K. Lees.
1991.
Clonal expansion precedes anergy and death of V 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.
Eur. J. Immunol.
21:1963-1966[Medline].
|
| 32.
|
MacHugh, N. D.,
P. L. J. Wijngaard,
H. C. Clevers, and W. C. Davis.
1993.
Clustering of monoclonal antibodies recognizing different members of the WC1 gene family.
Vet. Immunol. Immunopathol.
39:155-160[Medline].
|
| 33.
|
Marrack, P., and J. Kappler.
1990.
The staphylococcal enterotoxins and their relatives.
Science
248:705-711[Abstract/Free Full Text].
|
| 34.
|
Matsunaga, T.,
S. Kamata,
N. Kakiichi, and K. Uchida.
1993.
Characteristics of Staphylococcus aureus isolated from peracute, acute, and chronic bovine mastitis.
J. Vet. Med. Sci.
55:297-300[Medline].
|
| 35.
|
Migita, K., and A. Ochi.
1994.
Induction of clonal anergy by oral administration of staphylococcal enterotoxin B.
J. Immunol.
24:2081-2086.
|
| 36.
|
Morrison, W. I., and W. C. Davis.
1991.
Differentiation antigens expressed predominantly on CD4 CD8 T lymphocytes (WC1, WC2).
Vet. Immunol. Immunopathol.
27:71-76[Medline].
|
| 37.
|
Naessens, J.,
M. Sileghem,
N. Machugh,
W. C. Davis, and P. Toye.
1992.
Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene.
Immunology
76:305-309[Medline].
|
| 38.
|
Nielsen, M.,
A. Svejgaard,
C. Ropke,
M. Nordahl, and N. Odum.
1995.
Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Proc. Natl. Acad. Sci. USA
92:10995-10999[Abstract/Free Full Text].
|
| 39.
|
Ohashi, Y.,
T. Takeshita,
K. Nagata,
S. Mori, and K. Sugamura.
1989.
Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.
J. Immunol.
143:3548-3555[Abstract].
|
| 40.
|
Oliver, S. P., and B. A. Mitchell.
1984.
Prevalence of mastitis pathogens in herds participating in a mastitis control program.
J. Dairy Sci.
67:2436-2440.
|
| 41.
|
Park, Y. H.,
L. K. Fox,
M. J. Hamilton, and W. C. Davis.
1992.
Bovine mononuclear leucocyte subpopulations in peripheral blood and mammary gland secretions during lactation.
J. Dairy Sci.
75:998-1006[Abstract].
|
| 42.
|
Park, Y. H.,
L. K. Fox,
M. J. Hamilton, and W. C. Davis.
1993.
Suppression of proliferative response of BoCD4+ T lymphocytes by activated BoCD8+ T lymphocytes in the mammary gland of cows with Staphylococcus aureus mastitis.
Vet. Immunol. Immunopathol.
36:137-151[Medline].
|
| 43.
|
Schlievert, P.
1993.
Role of superantigens in human diseases.
J. Infect. Dis.
167:997-1002[Medline].
|
| 44.
|
Schlievert, P. M.,
K. J. Schoettie, and D. W. Watson.
1979.
Purification and physicochemical and biological characterization of staphylococcal pyrogenic exotoxin.
Infect. Immun.
23:609-617[Abstract/Free Full Text].
|
| 45.
|
Sopp, P.,
C. J. Howard, and K. R. Parsons.
1993.
A new non-lineage specific antigen with an Mw of 115 kDa and 39 kDa present on bovine leukocytes identified by monoclonal antibodies within BoWC10.
Vet. Immunol. Immunopathol.
29:209-215.
|
| 46.
|
Stohl, W., and J. E. Elliott.
1995.
Differential human T cell-dependent B cell differentiation induced by staphylococcal superantigens (SAg).
J. Immunol.
155:1838-1850[Abstract].
|
| 47.
|
Sundstedt, A.,
M. Dohlsten,
G. Hedlund,
I. Hoiden,
M. Bjorklund, and T. Kalland.
1994.
Superantigens anergize cytokine production but not cytotoxicity in vivo.
Immunology
82:117-125[Medline].
|
| 48.
|
Sundstedt, A.,
I. Hoiden,
J. Hansson,
G. Hedlund,
T. Kalland, and M. Dohlsten.
1995.
Superantigen-induced anergy in cytotoxic CD8+ T cells.
J. Immunol.
154:6306-6313[Abstract].
|
| 49.
|
Sutra, L., and B. Poutrel.
1994.
Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus.
J. Med. Microbiol.
40:79-89[Abstract].
|
| 50.
|
Wijngaard, P. L. J.,
N. D. MacHugh,
M. J. Metzelaar,
S. Romberg,
A. Bensaid,
L. Pepin,
W. C. Davis, and H. C. Clevers.
1994.
Members of the novel WC1 gene family are differentially expressed on subsets of bovine CD4 CD8  T-lymphocytes.
J. Immunol.
152:3476-3482[Abstract].
|
| 51.
|
Wijngaard, P. L. J.,
M. J. Metzelaar,
N. D. MacHugh,
W. I. Morrison, and H. C. Clevers.
1992.
Molecular characterization of the WC1 antigen expressed specifically on bovine CD4 CD8  T lymphocytes.
J. Immunol.
149:3273-3277[Abstract].
|
| 52.
|
Wyatt, C., R.,
C. Madruga,
C. Cluff,
S. Parish,
M. J. Hamilton,
W. Goff, and W. C. Davis.
1994.
Differential distribution of  T-cell receptor lymphocyte subpopulations in blood and spleen of young and adult cattle.
Vet. Immunol. Immunopathol.
40:187-199[Medline].
|
| 53.
|
Yokomizo, Y.,
Y. Mori,
Y. Shimoji,
S. Shimizu,
H. Sentsui,
M. Kodama, and H. Igarashi.
1995.
Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
J. Vet. Med. Sci.
2:299-305.
|
| 54.
|
Zar, J. H.
1984.
.
Biostatistical analysis, 2nd ed.
Prentice Hall, Inc., N.J.
|
Infect Immun, February 1998, p. 573-580, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Davis, T. L, Pate, J. L
(2007). Bovine Luteal Cells Stimulate Proliferation of Major Histocompatibility Nonrestricted Gamma Delta T Cells. Biol. Reprod.
77: 914-922
[Abstract]
[Full Text]
-
Moon, J. S., Lee, A. R., Kang, H. M., Lee, E. S., Joo, Y. S., Park, Y. H., Kim, M. N., Koo, H. C.
(2007). Antibiogram and Coagulase Diversity in Staphylococcal Enterotoxin-Producing Staphylococcus aureus from Bovine Mastitis. J DAIRY SCI
90: 1716-1724
[Abstract]
[Full Text]
-
Seo, K. S., Lee, S. U., Park, Y. H., Davis, W. C., Fox, L. K., Bohach, G. A.
(2007). Long-Term Staphylococcal Enterotoxin C1 Exposure Induces Soluble Factor-Mediated Immunosuppression by Bovine CD4+ and CD8+ T Cells. Infect. Immun.
75: 260-269
[Abstract]
[Full Text]
-
Tollersrud, T., Kampen, A. H., Kenny, K.
(2006). Staphylococcus aureus Enterotoxin D Is Secreted in Milk and Stimulates Specific Antibody Responses in Cows in the Course of Experimental Intramammary Infection.. Infect. Immun.
74: 3507-3512
[Abstract]
[Full Text]
-
Fueyo, J. M., Mendoza, M. C., Rodicio, M. R., Muniz, J., Alvarez, M. A., Martin, M. C.
(2005). Cytotoxin and Pyrogenic Toxin Superantigen Gene Profiles of Staphylococcus aureus Associated with Subclinical Mastitis in Dairy Cows and Relationships with Macrorestriction Genomic Profiles. J. Clin. Microbiol.
43: 1278-1284
[Abstract]
[Full Text]
-
Hu, D.-L., Cui, J.-C., Omoe, K., Sashinami, H., Yokomizo, Y., Shinagawa, K., Nakane, A.
(2005). A Mutant of Staphylococcal Enterotoxin C Devoid of Bacterial Superantigenic Activity Elicits a Th2 Immune Response for Protection against Staphylococcus aureus Infection. Infect. Immun.
73: 174-180
[Abstract]
[Full Text]
-
Komine, K.-i., Kuroishi, T., Komine, Y., Watanabe, K., Kobayashi, J., Yamaguchi, T., Kamata, S.-i., Kumagai, K.
(2004). Induction of Nitric Oxide Production Mediated by Tumor Necrosis Factor Alpha on Staphylococcal Enterotoxin C-Stimulated Bovine Mammary Gland Cells. CVI
11: 203-210
[Abstract]
[Full Text]
-
Kuroishi, T., Komine, K.-i., Asai, K.-i., Kobayashi, J., Watanabe, K., Yamaguchi, T., Kamata, S.-i., Kumagai, K.
(2003). Inflammatory Responses of Bovine Polymorphonuclear Neutrophils Induced by Staphylococcal Enterotoxin C via Stimulation of Mononuclear Cells. CVI
10: 1011-1018
[Abstract]
[Full Text]
-
Lee, S.-U., Ferens, W., Davis, W. C., Hamilton, M. J., Park, Y.-H., Fox, L. K., Naessens, J., Bohach, G. A.
(2001). Identity of Activation Molecule 3 on Superantigen-Stimulated Bovine Cells Is CD26. Infect. Immun.
69: 7190-7193
[Abstract]
[Full Text]
-
Akineden, O., Annemuller, C., Hassan, A. A., Lammler, C., Wolter, W., Zschock, M.
(2001). Toxin Genes and Other Characteristics of Staphylococcus aureus Isolates from Milk of Cows with Mastitis. CVI
8: 959-964
[Abstract]
[Full Text]
-
Yugueros, J., Temprano, A., Berzal, B., Sánchez, M., Hernanz, C., Luengo, J. M., Naharro, G.
(2000). Glyceraldehyde-3-Phosphate Dehydrogenase-Encoding Gene as a Useful Taxonomic Tool for Staphylococcus spp.. J. Clin. Microbiol.
38: 4351-4355
[Abstract]
[Full Text]
-
Ferens, W. A., Hovde, C. J.
(2000). Antiviral Activity of Shiga Toxin 1: Suppression of Bovine Leukemia Virus-Related Spontaneous Lymphocyte Proliferation. Infect. Immun.
68: 4462-4469
[Abstract]
[Full Text]
-
Soltys, J., Quinn, M. T.
(1999). Selective Recruitment of T-Cell Subsets to the Udder during Staphylococcal and Streptococcal Mastitis: Analysis of Lymphocyte Subsets and Adhesion Molecule Expression. Infect. Immun.
67: 6293-6302
[Abstract]
[Full Text]
-
Marcos, J. Y., Soriano, A. C., Salazar, M. S., Moral, C. H., Ramos, S. S., Smeltzer, M. S., Carrasco, G. N.
(1999). Rapid Identification and Typing of Staphylococcus aureus by PCR-Restriction Fragment Length Polymorphism Analysis of the aroA Gene. J. Clin. Microbiol.
37: 570-574
[Abstract]
[Full Text]
